Lord Abbett Developing Growth’s aggressive, momentum-driven approach can swing performance to extremes, but it has rewarded patient, long-term investors.
Lord Abbett Developing Growth Fund Class A LAGWX
- NAV / 1-Day Return $27.70 / −3.86 %
- Fund Size $1.9B
- Adjusted Expense Ratio 0.940%
- Net Expense Ratio 0.910%
- Fee Level: Distribution Low
- Share Class Type Front Load
- Morningstar Category Small Growth
- Equity Style Box (Funds) Small Growth
- Minimum Initial Investment $1,000
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 110%
Morningstar’s Analysis LAGWX
Will LAGWX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 22.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Guardant Health Inc | 3.09 | 62M | Healthcare |
Navan Inc Ordinary Shares - Class A | 2.77 | 55M | Technology |
JFrog Ltd Ordinary Shares | 2.67 | 53M | Technology |
10x Genomics Inc Ordinary Shares - Class A | 2.19 | 44M | Healthcare |
DigitalOcean Holdings Inc | 1.99 | 40M | Technology |
Twist Bioscience Corp | 1.98 | 40M | Healthcare |
SiTime Corp Ordinary Shares | 1.95 | 39M | Technology |
Madrigal Pharmaceuticals Inc | 1.85 | 37M | Healthcare |
Imax Corp | 1.80 | 36M | Communication Services |
Cogent Biosciences Inc | 1.78 | 36M | Healthcare |